Thomas Weisel Partners Holds First Annual Healthcare Investment Conference

HHS Secretary Tommy Thompson to Give Keynote Address; Exclusive Conference

On Specialty Pharmaceuticals, Drug Delivery and Healthcare Technology to Draw

Key Investors and Premier Companies



Apr 02, 2001, 01:00 ET from Thomas Weisel Partners LLC

    SAN FRANCISCO, April 2 /PRNewswire/ -- U.S. Department of Health and Human
 Services Secretary Tommy Thompson will keynote the first Healthcare Investment
 Conference held by Thomas Weisel Partners LLC, a merchant bank exclusively
 focused on the next generation of growth companies transforming the U.S.
 economy, at noon today at the Ritz Carlton Hotel in San Francisco.
     The two-day conference will provide an in-depth look at several areas of
 this fast-growing sector, including genomic and proteomic technologies, as
 well as focused sessions on drug development and discovery, clinical trials,
 DNA diagnostic s and other life science areas.
     The Healthcare Conference features presentations and panel discussions
 with top management of more than 50 companies, including PerkinElmer, Inc.,
 Celera Genomics Corp., Bruker Daltonics Inc., Applied Biosystems Group,
 Invitrogen Corporation and Forest Laboratories, Inc.  More than 120 investors
 are attending the invitation-only event.
     In addition, key members of Thomas Weisel Partners' Healthcare research
 team will lead panel discussions, including:
 
     Donald B. Ellis, Pharm D., Partner, Specialty Pharmaceuticals and Drug
      Delivery;
     Paul R. Knight, CFA, Partner, Life Science Technology;
     Scott R. Greenstone, CFA, Genomics & Proteomics;
     David Lewis, Molecular Diagnostics
 
     About Thomas Weisel Partners:
     Thomas Weisel Partners is a research-driven merchant bank providing
 investment banking, institutional brokerage, private client services, and
 private equity investing and asset management focused on transforming growth
 companies.  The Firm's distinctive competence is combining deep domain
 expertise with bulge bracket execution capability.  The team at Thomas Weisel
 Partners has over 800 employees, including 70 partners, and is headquartered
 in San Francisco with additional offices in New York, Boston, Menlo Park and
 London.  For more information about the firm, please visit our website at
 www.tweisel.com.
 
 

SOURCE Thomas Weisel Partners LLC
    SAN FRANCISCO, April 2 /PRNewswire/ -- U.S. Department of Health and Human
 Services Secretary Tommy Thompson will keynote the first Healthcare Investment
 Conference held by Thomas Weisel Partners LLC, a merchant bank exclusively
 focused on the next generation of growth companies transforming the U.S.
 economy, at noon today at the Ritz Carlton Hotel in San Francisco.
     The two-day conference will provide an in-depth look at several areas of
 this fast-growing sector, including genomic and proteomic technologies, as
 well as focused sessions on drug development and discovery, clinical trials,
 DNA diagnostic s and other life science areas.
     The Healthcare Conference features presentations and panel discussions
 with top management of more than 50 companies, including PerkinElmer, Inc.,
 Celera Genomics Corp., Bruker Daltonics Inc., Applied Biosystems Group,
 Invitrogen Corporation and Forest Laboratories, Inc.  More than 120 investors
 are attending the invitation-only event.
     In addition, key members of Thomas Weisel Partners' Healthcare research
 team will lead panel discussions, including:
 
     Donald B. Ellis, Pharm D., Partner, Specialty Pharmaceuticals and Drug
      Delivery;
     Paul R. Knight, CFA, Partner, Life Science Technology;
     Scott R. Greenstone, CFA, Genomics & Proteomics;
     David Lewis, Molecular Diagnostics
 
     About Thomas Weisel Partners:
     Thomas Weisel Partners is a research-driven merchant bank providing
 investment banking, institutional brokerage, private client services, and
 private equity investing and asset management focused on transforming growth
 companies.  The Firm's distinctive competence is combining deep domain
 expertise with bulge bracket execution capability.  The team at Thomas Weisel
 Partners has over 800 employees, including 70 partners, and is headquartered
 in San Francisco with additional offices in New York, Boston, Menlo Park and
 London.  For more information about the firm, please visit our website at
 www.tweisel.com.
 
 SOURCE  Thomas Weisel Partners LLC